Skip to main content
OpenTrials

Clinical trial condition

Stage IIIC Breast Cancer AJCC v7

Explore clinical trials studying Stage IIIC Breast Cancer AJCC v7. Study availability and eligibility vary by location and protocol.

32 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Stage IIIC Breast Cancer AJCC v7 trial results

Active, not recruiting

Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy

NCT03281902

Conditions
Advanced Breast Carcinoma, Breast Diseases, Breast Neoplasms, +12 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
View Trial Details
Completed

Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

NCT00770809

Conditions
Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +10 more
Locations
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • Sparks Regional Medical Center Fort Smith, Arkansas, United States
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
  • East Bay Radiation Oncology Center Castro Valley, California, United States
View all 318 locations
View Trial Details
Completed

Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence

NCT04054557

Conditions
Breast Carcinoma In Situ, Breast Diseases, Breast Neoplasms, +19 more
Locations
  • Jefferson Health - South Jersey Washington Township, New Jersey, United States
  • Thomas Jefefrson University Philadelphia, Pennsylvania, United States
  • Methodist Hospital Philadelphia, Pennsylvania, United States
  • Jefferson Health - Northeast Torresdale, Pennsylvania, United States
View Trial Details
Completed

Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer

NCT02003209

Conditions
Breast Diseases, Breast Neoplasms, HER2-Positive Breast Carcinoma, +11 more
Locations
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • CHI Saint Vincent Cancer Center Hot Springs Hot Springs, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
  • Kaiser Permanente-Deer Valley Medical Center Antioch, California, United States
View all 732 locations
View Trial Details

Related conditions